<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="../css/strict.xsl"?>
<PAGE status="unmaintained" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="../css/schema.xsd">
<TITLE>Clinical Trials</TITLE>
<PATH>links/clinicaltrial.xml</PATH>
<DATE><YEAR>2014</YEAR><MONTH>4</MONTH><DAY>6</DAY></DATE>
<CONTENT>
<LLIST>
  <ITEM><SLIST>
    <ITEM><CLIST>
      <ITEM><X><T>Bio IT World</T><A>http://www.bio-itworld.com</A><L>fr</L><F>HTML</F><FEED><A>http://www.bio-itworld.com/xml/index/feed.rss</A><F>RSS</F></FEED></X></ITEM>
      <ITEM><X><T>Applied Clinical Trials</T><A>http://www.appliedclinicaltrialsonline.com</A><L>fr</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>goBalto</T><A>http://www.gobalto.com</A><L>fr</L><F>HTML</F></X></ITEM>
    </CLIST></ITEM>
    <ITEM><CLIST>
      <ITEM><X><T>ClinPage</T><A>http://www.clinpage.com</A><L>fr</L><F>HTML</F><FEED><A>http://feeds.feedburner.com/ClinPage</A><F>RSS</F></FEED></X></ITEM>
      <ITEM><X><T>PharmaVOICE</T><A>http://www.pharmavoice.com</A><L>fr</L><F>HTML</F></X></ITEM>
    </CLIST></ITEM>
    <ITEM><X><T>DIA</T><A>http://www.diahome.org</A><L>en</L><F>HTML</F></X></ITEM>
    <ITEM><X><T>eClinical Forum</T><A>http://www.eclinicalforum.org</A><L>en</L><F>HTML</F></X></ITEM>
    <ITEM><CLIST><TITLE>SAS</TITLE>
      <ITEM><X><T>PROC CDISC</T><A>https://support.sas.com/documentation/cdl/en/cdisc/60755/HTML/default/viewer.htm</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>XMLMap in SAS 8.2</T><A>https://support.sas.com/rnd/base/xmlengine/sxle82/exp82/mapxmlexp.html</A><L>en</L><F>HTML</F></X></ITEM>
    </CLIST></ITEM>
    <ITEM><BLIST><TITLE>Books</TITLE>
      <ITEM><X><T>Randomization in Clinical Trials</T><A>https://books.google.com/books?id=Wy0hy4DPEPQC</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Management of Data in Clinical Trials</T><A>https://books.google.com/books?id=5npQY8o_OzkC</A><L>en</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
    <ITEM><CLIST><TITLE>Glossaries</TITLE>
      <ITEM><X quality='1'><T>CDISC</T><A>https://www.cdisc.org/cdisc-glossary</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>CenterWatch</T><A>https://www.centerwatch.com/health-resources/glossary/</A><L>en</L><F>HTML</F></X></ITEM>
    </CLIST></ITEM>
    <ITEM><X><T>CRFQ</T><A>https://hssp-cohort.wikispaces.com/</A><L>en</L><F>HTML</F></X></ITEM>
    <ITEM><X><T>CDE Browser</T><A>https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html</A><L>en</L><F>HTML</F></X></ITEM>
    <ITEM><CLIST><TITLE>Miscellaneous</TITLE>
      <ITEM><X><T>decidemedical</T><A>http://www.decidemedical.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Data Management Biomédical</T><A>http://www.dmb-asso.org</A><L>fr</L><F>HTML</F></X></ITEM>
    </CLIST></ITEM>
    <ITEM><BLIST><TITLE>Scorings</TITLE>
      <ITEM><X><T>Orthopaedic Scores</T><A>http://www.orthopaedicscore.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Traumascores.de</T><A>http://www.traumascores.com</A><L>de</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>SF36 / SF12 / SF8</T><A>http://www.sf-36.org</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>EQ-5D</T><A>http://www.euroqol.org</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>ODI - Oswestry Disability Index (aka: Oswestry Low Back Pain Disability Questionnaire)</T><A>http://www.chirogeek.com/001_Oswestry_20.htm</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>RMQ - Roland-Morris Questionnaire</T><A>http://www.chirogeek.com/001_Roland-Morris-Questionnaire.htm</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Stanford Score</T><A>http://www.chirogeek.com/001_Stanford-Score.htm</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Neck Disability Index</T><A>http://www.chirogeek.com/001_Neck-Disability-Index.htm</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>euroSCORE</T><A>http://www.euroscore.org</A><L>en</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Clinical trial registries</TITLE>
      <ITEM><X><T>clinicaltrials.gov</T><A>http://www.clinicaltrials.gov</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>ClinicalStudyResults.org</T><A>http://www.clinicalstudyresults.org</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>ICTRP</T><A>https://www.who.int/ictrp</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Stroke</T><A>http://www.strokecenter.org/trials</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Acurian</T><A>https://www.acurian.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>CenterWatch</T><A>https://www.centerwatch.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>essai-clinique.com</T><A>http://essai-clinique.com</A><L>fr</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
  </SLIST></ITEM>
  <ITEM><BLIST><TITLE>Articles</TITLE>
    <ITEM><BLIST><TITLE>ICH</TITLE>
      <ITEM><ARTICLE><X><T>Guideline for Good Clinical Practice E6(R1)</T><A>http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>1996</YEAR><MONTH>6</MONTH><DAY>10</DAY></DATE><COMMENT>ICH's guidelines for clinical trials.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>IHE</TITLE>
      <ITEM><BLIST><TITLE>EHR/EDC connection</TITLE>
        <ITEM><BLIST><TITLE>RFD</TITLE>
          <ITEM><ARTICLE><X><T>IHE IT Infrastructure Technical Framework Supplement 2007-2008 - Retrieve Form for Data Capture (RFD)</T><A>http://www.ihe.net/Technical_Framework/upload/IHE_ITI_TF_Supplement_RFD_TI_2007_08_15.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2007</YEAR><MONTH>8</MONTH><DAY>15</DAY></DATE><COMMENT>The draft of the RFD profile.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>CDISC Showcases Interoperability Prototype between Medical Research and Healthcare</T><A>http://www.businesswire.com/news/home/20070410005821/en/CDISC-Showcases-Interoperability-Prototype-Medical-Research-Healthcare#.Uzx00lddBDs</A><L>en</L><F>HTML</F></X><DATE><YEAR>2007</YEAR><MONTH>4</MONTH><DAY>10</DAY></DATE><COMMENT>CDISC and IHE work together to obtain EHR/EDC interoperability.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X status='dead'><T>Is the water boiling yet? ~or~ How close are we to an interoperable world between Healthcare and Clinical Research?</T><A>https://www.cdisc.org/newsletter/issues/NOV2008/2008SCDM.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>4</DAY></DATE><COMMENT>RFD has been demonstrated at CDISC International Interchange 2008.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>Clinical Research Data Capture Fields</T><A>http://wiki.ihe.net/index.php?title=Clinical_Research_Data_Capture_Fields</A><L>en</L><F>HTML</F></X><COMMENT>Some information about the Clinical Research Data Capture Fields which builds on top of RFD.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
      </BLIST></ITEM>
      <ITEM><ARTICLE><X><T>Case Report Forms to Get Digital Signature Capability</T><A>http://www.bio-itworld.com/ecliniqua/2008/10/06/safe-biopharma-digital-signatures.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>10</MONTH><DAY>6</DAY></DATE><COMMENT>A demonstration of RFD where the CRF is signed using SAFE.</COMMENT></ARTICLE></ITEM>
      <ITEM><ARTICLE><X><T>Workgroup Sets Priorities to Harmonize Standards for EHRs and Research</T><A>http://www.bio-itworld.com/news/2009/01/05/workgroup-sets-EHR-standards.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>5</DAY></DATE><COMMENT>ANSI creates the EHR Clinical Research Value Case Workgroup.</COMMENT></ARTICLE></ITEM>
      <ITEM><ARTICLE><X><T>HL7 Announces Industry’s First Electronic Health Record System (EHR-S) Functional Requirements Standard for Clinical Research</T><A>http://www.hl7.org/documentcenter/public/pressreleases/HL7_PRESS_20091105.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>5</DAY></DATE><COMMENT>HL7 defines high-level requirements for using EHR data for clinical research.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Pharma market</TITLE>
      <ITEM><ARTICLE><X><T>Drug industry lopping off jobs</T><A>http://www.baltimoresun.com/business/bal-bz.pharma04aug04,0,4794457.story</A><L>en</L><F>HTML</F></X><DATE><YEAR>2007</YEAR><MONTH>8</MONTH><DAY>4</DAY></DATE><COMMENT>The future of pharma companies is less rosy with the patent expirations of the big sellers.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Clinical trials</TITLE>
      <ITEM><BLIST><TITLE>General information</TITLE>
        <ITEM><ARTICLE><X><T>Medical Statistics - A practical guide - Statistics and the Role of the Statistician in Clinical Trial Research</T><A>../attic/pp_nov05.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2005</YEAR><MONTH>11</MONTH></DATE><COMMENT>An overview of the role of the statistician during a clinical trial.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Improving Protocol Quality</T><A>http://www.actmagazine.com/appliedclinicaltrials/data/articlestandard/appliedclinicaltrials/222002/20157/article.pdf</A><L>en</L><F>PDF</F></X><X><T>Improving Protocol Quality</T><A>http://www.fast-track.com/pdfs/Model_based_method.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Michael</FIRSTNAME><MIDDLENAME>G.</MIDDLENAME><LASTNAME>Kahn</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Carol</FIRSTNAME><MIDDLENAME>A.</MIDDLENAME><LASTNAME>Broverman</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Nancy</FIRSTNAME><LASTNAME>Wu</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Wendy</FIRSTNAME><MIDDLENAME>J.</MIDDLENAME><LASTNAME>Farnsworth</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Lenilyn</FIRSTNAME><LASTNAME>Manlapaz-Espiritu</LASTNAME></AUTHOR><DATE><YEAR>2002</YEAR><MONTH>4</MONTH></DATE><COMMENT>The authors explain that a formal description and review of a protocol helps improving it (this would be obvious for anyone who has used formal modelling in another area, such as UML in IT…). These are the starting ideas of the FastTrack product.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Exploratory INDs: A Trial Before the Trials</T><A>http://www.bio-itworld.com/issues/2007/dec-jan/cover-story-exploratory-inds/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Mike</FIRSTNAME><LASTNAME>May</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>12</MONTH><DAY>17</DAY></DATE><COMMENT>This article describes what are phase 0 trials and why they are currently more and more used.</COMMENT></ARTICLE></ITEM>
        <ITEM><BLIST><TITLE>Adaptive clinical trials</TITLE>
          <ITEM><ARTICLE><X><T>Commentary: Adaptive Trials in Practice</T><A>http://www.bio-itworld.com/newsitems/2007/nov/adaptive-trials-in-practice/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Michael</FIRSTNAME><LASTNAME>Rosenberg</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>11</MONTH><DAY>19</DAY></DATE><COMMENT>A short description of what are adaptive studies and what is required to perform them.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>Many Unknowns Surround Novel Trial Designs</T><A>http://www.bio-itworld.com/ecliniqua/2008/03/24/adaptive-clinical-trial-design.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>3</MONTH><DAY>24</DAY></DATE><COMMENT>The usage of adaptive clinical trials is still very limited due to the limited experience we have with them.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
        <ITEM><ARTICLE><X><T>Medical Imaging Core Laboratories</T><A>http://actmagazine.findpharma.com/appliedclinicaltrials/Laboratories/Medical-Imaging-Core-Laboratories/ArticleStandard/Article/detail/182766?contextCategoryId=3118</A><L>en</L><F>HTML</F></X><DATE><YEAR>2005</YEAR><MONTH>10</MONTH><DAY>2</DAY></DATE><COMMENT>Imaging core laboratories are playing a larger and larger role in clinical trials and the FDA has produced some guidances for using images as an endpoint.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X protection='free_registration'><T>Clarified protocol issued for studies without informed consent</T><A>https://www.auntminnie.com/index.asp?Sec=sup&amp;Sub=car&amp;Pag=dis&amp;ItemId=77884</A><L>en</L><F>HTML</F></X><DATE><YEAR>2007</YEAR><MONTH>10</MONTH><DAY>12</DAY></DATE><COMMENT>AHA proposes recommendations when a unconscious patient (hence he cannot give his consent) participates to a clinical trial.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Performance Management in Large Cohort Clinical Registry : Confessions of a clinical expert</T><A>http://blog.evidence-performance.com/2008/08/27/confessions-of-a-clinical-trial-manager/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>8</MONTH><DAY>27</DAY></DATE><COMMENT>Some information on managing clinical trials with a large cohort and some thoughts on missing performance metrics.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Citeline Finds Trial Trends Don’t Apply to All Diseases</T><A>http://www.bio-itworld.com/ecliniqua/2009/01/26/citeline-tracks-trials.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>26</DAY></DATE><COMMENT>Analyzing the number and size of clinical trials for some diseases.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X protection='free_registration'><T>Clinical Trials, Wrapped in Red Tape</T><A>https://www.nytimes.com/2009/08/08/opinion/08satel.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Sally</FIRSTNAME><LASTNAME>Satel</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>8</MONTH><DAY>7</DAY></DATE><COMMENT>Clinical trials, because of IRB approvals, are getting too much difficult and expensive.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Sponsors, Sites Reach Consensus on Six Best Practices</T><A>http://www.bio-itworld.com/eCliniqua_article.aspx?id=95116</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>16</DAY></DATE><COMMENT>Train staff to Good Clinical Practice, have an ongoing compliance program in place, answer to monitoring reports as for a CAPA, ask for a post-study "report card", request monthly payment terms, and support education of the general public.</COMMENT></ARTICLE></ITEM>
        <ITEM><BLIST><TITLE>Simulating and visualizing patient enrolment</TITLE>
          <ITEM><ARTICLE><X status='dead'><T>Visualizing Patient Enrollment</T><A>http://eclinicalopinion.blogspot.com/2009/12/visualizing-patient-enrollment.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>12</MONTH><DAY>29</DAY></DATE><COMMENT>The author explains how he created his simple patient enrolment visualization and …</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X status='dead'><T>Simulating Patient Enrolment</T><A>http://eclinicalopinion.blogspot.com/2010/01/simulating-patient-enrolment.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>1</MONTH><DAY>4</DAY></DATE><COMMENT>… simulation.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X status='dead'><T>Revisiting Patient Enrollment Visualization</T><A>http://eclinicalopinion.blogspot.com/2010/03/revisiting-patient-enrollment.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>3</MONTH><DAY>26</DAY></DATE><COMMENT>The author performs a larger simulation and visualisation, and cogitates further about the simulation.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
        <ITEM><ARTICLE><X><T>Strong Uptake for Site-Specific CTMS</T><A>http://www.bio-itworld.com/eCliniqua_article.aspx?id=95815</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>12</MONTH><DAY>14</DAY></DATE><COMMENT>Bio-Optronics and ClinTrial Works are selling CTMS software to sites to help them manage patient recruitment, follow-up visits, stipends…</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Sanofi’s Relationship Overhaul</T><A>http://www.clinpage.com/article/sanofi_relationship_overhaul/C24</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Suz</FIRSTNAME><LASTNAME>Redfearn</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>1</MONTH><DAY>22</DAY></DATE><COMMENT>Sanofi-Aventis improves its relation with the sites: more frequent and timely payments, more trained monitor, faster EDC…</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X quality='-1'><T>Implementing Core Clinical Trial Technologies</T><A>http://www.bio-itworld.com/2010/02/16/implementing-core-tech.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Bill</FIRSTNAME><LASTNAME>Byrom</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>2</MONTH><DAY>16</DAY></DATE><COMMENT>This article states the obvious: integration of CTMS, EDC and RTSM results in an increased efficiency.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Studies May Soon be Monitored Less Frequently—or From Afar</T><A>http://www.healthtech.com/eCliniqua_article.aspx?id=97280</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>3</MONTH><DAY>1</DAY></DATE><COMMENT>The Clinical Trials Transformation Initiative proposes to perform a risk-based remote monitoring.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Electronic Endpoint Adjudication</T><ST>How an integrated, EDC-based system can optimize the endpoint process</ST><A>http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/article/articleDetail.jsp?id=660940</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Cathy</FIRSTNAME><LASTNAME>Tyner</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Zaher</FIRSTNAME><LASTNAME>El-Assi</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>3</MONTH><DAY>1</DAY></DATE><COMMENT>Some proselytism for online adjudication.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Computing Stephen</T><A>http://www.bio-itworld.com/2010/08/04/computing-stephen.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Davies</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>8</MONTH><DAY>4</DAY></DATE><COMMENT>Jamie Heywood thinks that scientists in pharmaceutical companies are not rigorous when choosing drug candidates and managing clinical tests, IT engineers would do a better work.</COMMENT></ARTICLE></ITEM>
        <ITEM><BLIST><TITLE>SDV</TITLE>
          <ITEM><ARTICLE><X><T>Efficient Source Data Verification</T><A>http://medind.nic.in/ibi/t00/i3/ibit00i3p180.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>R.</FIRSTNAME><LASTNAME>Khosla</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>D.</FIRSTNAME><MIDDLENAME>D.</MIDDLENAME><LASTNAME>Verma</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>A.</FIRSTNAME><LASTNAME>Kapur</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>S.</FIRSTNAME><LASTNAME>Khosla</LASTNAME></AUTHOR><DATE><YEAR>2000</YEAR><MONTH>2</MONTH><DAY>1</DAY></DATE><COMMENT>A good overview of what is SDV: its purpose, what should be verified, how to perform the verification…</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X status='dead'><T>Could 100% Source Document Verification Become a Risk in a Fixed-Unit Price Environment?</T><A>http://www.researchpoint.com/200712ACRP-BreslauerArticle.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Carol</FIRSTNAME><LASTNAME>Breslauer</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR></DATE><COMMENT>The author explains that the monitoring goals should be analyzed in order to properly estimate the workload. A 100% SDV is not necessary, the SDV coverage should be defined according to the criticality of the data and, possibly, the site error rate.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Clinical trial registries</TITLE>
        <ITEM><ARTICLE><X quality='1' status='dead'><T>WHO International Clinical Trial Registry Platform - What is the Value of Registering?</T><A>http://www.bettermanagement.com/seminars/seminar.aspx?l=13423</A><L>en</L><F>RealMedia</F><DURATION><HOUR>1</HOUR><MINUTE>1</MINUTE><SECOND>43</SECOND></DURATION></X><AUTHOR><FIRSTNAME>Edward</FIRSTNAME><MIDDLENAME>D.</MIDDLENAME><LASTNAME>Helton</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Ida</FIRSTNAME><LASTNAME>Sim</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR><MONTH>3</MONTH><DAY>13</DAY></DATE><COMMENT>A good presentation of WHO's ICTRP: a worldwide register for clinical trials.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>The Global Trial Bank - Meeting the Needs of the International Biopharma Community and the Patients it Serves</T><A>http://www.bettermanagement.com/seminars/seminar.aspx?l=13738</A><L>en</L><F>RealMedia</F><DURATION><HOUR>1</HOUR><MINUTE>3</MINUTE><SECOND>45</SECOND></DURATION></X><AUTHOR><FIRSTNAME>Don</FIRSTNAME><LASTNAME>Detmer</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR><MONTH>4</MONTH><DAY>19</DAY></DATE><COMMENT>A short and very abstract presentation of the Global Trial Bank (an AMIA initiative to centralize the design, execution, and results of Clinical Trials).</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Adverse Event Reporting Begins at Clinicaltrials.gov</T><A>http://www.bio-itworld.com/2009/09/21/AE-reporting.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>9</MONTH><DAY>21</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Some studies</TITLE>
        <ITEM><BLIST><TITLE>Tuskegee Study</TITLE>
          <ITEM><ARTICLE><X><T>U.S. Public Health Service Syphilis Study at Tuskegee</T><A>https://www.cdc.gov/tuskegee</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>1</MONTH><DAY>9</DAY></DATE><COMMENT>The CDC gives some information on the study, including the text of the presidential apology.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>Tuskegee Study of Untreated Syphilis in the Negro Male</T><A>https://en.wikipedia.org/wiki/Tuskegee_Study_of_Untreated_Syphilis_in_the_Negro_Male</A><L>en</L><F>HTML</F></X><COMMENT>The Wikipedia article.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
        <ITEM><BLIST><TITLE>TGN1412</TITLE>
          <ITEM><ARTICLE><X><T>Clinical trial suspension: latest findings</T><A>http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;ssDocName=CON2023515&amp;ssTargetNodeId=389</A><L>en</L><F>HTML</F></X><DATE><YEAR>2006</YEAR><MONTH>4</MONTH><DAY>5</DAY></DATE><COMMENT>The MHRA report on the TGN1412 clinical trials accident (2006, 13<SUP>th</SUP> March).</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>TGN1412</T><A>https://en.wikipedia.org/wiki/TGN1412</A><L>en</L><F>HTML</F></X><COMMENT>The Wikipedia article.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
        <ITEM><BLIST><TITLE>tgAAC94</TITLE>
          <ITEM><ARTICLE><X><T>Death Points to Risks in Research</T><ST>One Woman's Experience in Gene Therapy Trial Highlights Weaknesses in the Patient Safety Net</ST><A>http://www.washingtonpost.com/wp-dyn/content/article/2007/08/05/AR2007080501636.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Rick</FIRSTNAME><LASTNAME>Weiss</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>8</MONTH><DAY>6</DAY></DATE><COMMENT>A death may be related to the clinical trial. Whatever the link is, some dubious points appear in the way the case was handled.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>Gene therapy unlikely cause in death</T><ST>Recent tests run by University of Chicago scientists point to the innocence of Targeted Genetics' gene therapy for inflammatory arthritis…</ST><A>https://seattletimes.nwsource.com/html/businesstechnology/2004005471_targeted10.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ángel</FIRSTNAME><LASTNAME>González</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>11</MONTH><DAY>10</DAY></DATE><COMMENT>Jolee Mohr's death seems to be unrelated to tgAAC94 injection.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
      </BLIST></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Coding</TITLE>
      <ITEM><ARTICLE><X><T>MedDRA - An Introduction</T><A>http://www.rti.org/pubs/meddra_intro.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Michael</FIRSTNAME><MIDDLENAME>J.</MIDDLENAME><LASTNAME>Klepper</LASTNAME></AUTHOR><DATE><YEAR>2005</YEAR></DATE><COMMENT>A good presentation of MedDRA.</COMMENT></ARTICLE></ITEM>
      <ITEM><ARTICLE><X><T>Frequently Asked Questions - WHO Drug</T><A>http://www.thesisinc.com/faq-whodrug.html</A><L>en</L><F>HTML</F></X><COMMENT>A short presentation of WHO Drug and the possible issues when coding with it.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Imaging</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Reading Medical Images in Oncology Clinical Trials</T><A>http://www.bioimaging.com/assets/pdf/Reading_Medical_Images_in_Oncology_Clinical_Trials.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Gollin</FIRSTNAME><MIDDLENAME>G</MIDDLENAME><LASTNAME>Miller</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Klaus</FIRSTNAME><LASTNAME>Noever</LASTNAME></AUTHOR><DATE><YEAR>2004</YEAR></DATE><COMMENT>A description of the processes (blinding, double read…) of an ICL for an oncology clinical trial.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>eClinical: Imaging Solutions</T><A>../attic/eClinical_Imaging_Solutions_EPC_DEC_08.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Gunter</FIRSTNAME><LASTNAME>Bellaire</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Jaynes</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Bill</FIRSTNAME><LASTNAME>Byrom</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR></DATE><COMMENT>After explaining the advantages of integrating images with the EDC, IVRS…, they explain that using a middleware is a better solution than a point-to-point integration.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>High-Tech Trials</T><A>http://www.imagingeconomics.com/2008/12/high-tech-trials/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Gunter</FIRSTNAME><LASTNAME>Bellaire</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Jaynes</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>12</MONTH></DATE><COMMENT>A short overview of the tasks and the process of an Imaging CoreLab during a clinical trial.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Images: Read On Site or Centrally and Independently?</T><A>http://www.bio-itworld.com/issues/2010/jan/radmd.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>12</MONTH><DAY>14</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Miscellaneous</TITLE>
      <ITEM><ARTICLE><X><T>Infinity’s EDC Evolution</T><A>http://www.bio-itworld.com/2008/07/07/infinity-edc.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Davies</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>7</MONTH><DAY>7</DAY></DATE ><COMMENT>A description of the RDC/CTMS build and used by Infinity.</COMMENT></ARTICLE></ITEM>
    </BLIST></ITEM>
  </BLIST></ITEM>
</LLIST>
</CONTENT>
</PAGE>